Misplaced Pages

OrthoCor

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Misplaced Pages's content policies, particularly neutral point of view. Please discuss further on the talk page. (June 2013) (Learn how and when to remove this message)
This article contains promotional content. Please help improve it by removing promotional language and inappropriate external links, and by adding encyclopedic text written from a neutral point of view. (December 2012) (Learn how and when to remove this message)
This article may require cleanup to meet Misplaced Pages's quality standards. The specific problem is: most of the article reads like an advert. Please help improve this article if you can. (December 2012) (Learn how and when to remove this message)
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "OrthoCor" – news · newspapers · books · scholar · JSTOR (December 2012) (Learn how and when to remove this message)
(Learn how and when to remove this message)
OrthoCor Medical, Inc.
OrthoCor Medical Logo
Company typePrivate
IndustryMedical Technology
HeadquartersArden Hills, Minnesota
Key peopleFariborz Boor Boor
ProductsOrthoCor Active System
Websitewww.orthocormedical.com

OrthoCor Medical, Inc. is a privately owned medical device company based in Arden Hills, Minnesota. Founded in 2007, OrthoCor develops drug-free, noninvasive, mobile medical devices aimed at alleviating pain and reducing edema.

History

The company initially worked to address the untapped market between analgesics and joint replacement surgery. In 2009, OrthoCor received Class III clearance from the U.S. Food and Drug Administration (FDA) for the Active System.

In August 2010, the company introduced the OrthoCor Active System, a Class III medical device, following approval from the FDA. The OrthoCor Active System is indicated for adjunctive use in the palliative treatment of post-operative pain and edema in superficial soft tissue.

Awards

In 2012, OrthoCor was named the winner of The Minnesota Cup At the 9th Annual LifeScience Alley Expo event, OrthoCor was a winner of the New Technology Show Case sponsored by Boston Scientific.

References

  1. striblee. "OrthoCor Medical secures $2.4 million in angel investment". Star Tribune. Retrieved 2023-08-30.
  2. "Minnesota Cup Competition Names 2012 Finalists". Twin Cities Business. 2012-08-31. Retrieved 2023-08-30.

External links

Categories:
OrthoCor Add topic